MiRNA-based Regenerative therapy for DM: MiRNA-29c increases insulin-secreting cell mass and function via up regulation of its target genes, 31/October/2014, 7.00 am

Natural product-based therapy for Cancer: Phloretin decreases glutathione levels, increases reactive oxygen species levels and inhibits cancer cell proliferation via up regulation of its target gene, 31/October/2014, 5.59 am
October 31, 2014
Chemopreventive therapy against Human Cancer: Chitosan oligosaccharides (CO) inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 1/November/2014, 7.24 am
November 1, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based Regenerative therapy for DM: MiRNA-29c increases insulin-secreting cell mass and function via up regulation of its target genes, 31/October/2014, 7.00 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that MiRNA-29c, by decreasing the expression of its target gene, it may increase insulin-secreting cell mass and functionThereby, it may increase the insulin sensitivity of cellular tissues.  Thus, pharmacological formulations encompassing “MiRNA-29c or its activators”  can be used to treat DM.

Amount: $ 300

Undisclosed information: How MiRNA-29c increases insulin-secreting cell mass and function. 

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.